Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.
Many types of adverse drug reactions appear to involve reactive metabolites which, by their very nature, usually have short biological half-lives. Therefore, reactive metabolites formed by neutrophils, or neutrophil precursors in the bone marrow, would seem more likely to be responsible for drug-induced agranulocytosis than metabolites formed in the liver. We have found that several drugs associated with a relatively high incidence of drug-induced agranulocytosis are metabolised by activated neutrophils to chemically reactive metabolites. In preliminary experiments with clozapine, we found that clozapine was metabolised by neutrophils. It also reacted with hypochlorous acid, the principal oxidant generated by neutrophils, to form a reactive intermediate. This intermediate has a half-life of 1 minute in buffer, but reacts very rapidly with glutathione. We believe that this intermediate is a nitrenium ion. Such a metabolite could be responsible for clozapine-induced agranulocytosis, either by direct toxicity or through an immune-mediated mechanism.
Uetrecht
J P
JP
Faculty of Pharmacy, University of Toronto, Canada.
D000380:Agranulocytosis / Q000139:chemically induced* / Q000378:metabolism*; D003024:Clozapine / Q000009:adverse effects / Q000097:blood*; D006801:Humans; D009504:Neutrophils / Q000378:metabolism*
D003024:Clozapine